Immunological basis of stem cell therapy in liver diseases

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Expert Review of Clinical Immunology

• Publication date

  2014-08-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1586/1744666X.2014.930665PMID 24964800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized controlled trial

  2016cited by this paper
• Th17/Treg imbalance in triptolide-induced liver injury.

  2014cited by this paper
• Increased activated natural killer T cells in the liver of patients with advanced stage primary biliary cirrhosis.

  2014cited by this paper
• Cleavage of the T Cell Protein Tyrosine Phosphatase by the Hepatitis C Virus Nonstructural 3/4A Protease Induces a Th1 to Th2 Shift Reversible by Ribavirin Therapy

  2014influential reference
• Pluripotent stem cell-derived hepatocyte-like cells.

  2014cited by this paper
• Macrophage heterogeneity in liver injury and fibrosis.

  2014cited by this paper
• Mesenchymal stem cell therapy in proteoglycan induced arthritis

  2014influential reference
• Human mesenchymal stem cells suppress donor CD4+ T cell proliferation and reduce pathology in a humanized mouse model of acute graft‐versus‐host disease

  2013cited by this paper
• A novel TH17-type cell is rapidly increased in the liver in response to acetaminophen-induced liver injury: TH17 cells and the innate immune response

  2013cited by this paper
• Early IL-17 Production by Intrahepatic T Cells Is Important for Adaptive Immune Responses in Viral Hepatitis

  2013cited by this paper
• Human amniotic fluid stem cells suppress PBMC proliferation through IDO and IL-10-dependent pathways.

  2013cited by this paper
• Alveolar Macrophages Are Critical for the Inhibition of Allergic Asthma by Mesenchymal Stromal Cells

  2013cited by this paper
• Serum-starved adipose-derived stromal cells ameliorate crescentic GN by promoting immunoregulatory macrophages.

  2013cited by this paper
• Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrier.

  2013cited by this paper
• Immune Therapeutic Potential of Stem Cells from Human Supernumerary Teeth

  2013cited by this paper
• Bone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17

  2013cited by this paper
• PD‐1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication

  2013cited by this paper
• Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow

  2013cited by this paper
• Regulatory T cells inhibit Th1 cell-mediated bile duct injury in murine biliary atresia.

  2013cited by this paper
• Mesenchymal stem cell-conditioned medium reduces liver injury and enhances regeneration in reduced-size rat liver transplantation.

  2013influential reference
• In Vivo Tracking and Comparison of the Therapeutic Effects of MSCs and HSCs for Liver Injury

  2013cited by this paper
• Autologous Bone Marrow Mononuclear Cell Transplantation in Patients with Decompensated Alcoholic Liver Disease: A Randomized Controlled Trial

  2013cited by this paper
• Restoration of intrahepatic regulatory T cells through MMP-9/13-dependent activation of TGF-β is critical for immune homeostasis following acute liver injury.

  2013cited by this paper
• Induction of Regulatory T Cells by High-Dose gp96 Suppresses Murine Liver Immune Hyperactivation

  2013cited by this paper
• NKT-cell subsets: promoters and protectors in inflammatory liver disease.

  2013cited by this paper
• Association of age‐dependent liver injury and fibrosis with immune cell populations

  2013cited by this paper
• A pilot study of umbilical cord‐derived mesenchymal stem cell transfusion in patients with primary biliary cirrhosis

  2013cited by this paper
• Adipose tissue derived stromal stem cell therapy in murine ConA‐derived hepatitis is dependent on myeloid‐lineage and CD4+ T‐cell suppression

  2013cited by this paper
• The immunobiology and pathophysiology of primary biliary cirrhosis.

  2013cited by this paper
• Changes in peripheral blood Th1 and Th2 cells in rat liver transplantation under different immune statuses.

  2013cited by this paper
• Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis

  2012cited by this paper
• Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP‐12) during experimental liver fibrosis

  2012cited by this paper
• Phase II Trial: Undifferentiated Versus Differentiated Autologous Mesenchymal Stem Cells Transplantation in Egyptian Patients with HCV Induced Liver Cirrhosis

  2012cited by this paper
• Impaired immunomodulatory ability of bone marrow mesenchymal stem cells on CD4(+) T cells in aplastic anemia.

  2012influential reference
• Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients

  2012cited by this paper
• Bone Marrow-Derived Conventional, But Not Cloned, Mesenchymal Stem Cells Suppress Lymphocyte Proliferation and Prevent Graft-Versus-Host Disease in Rats

  2012cited by this paper
• The Role of Mouse Mesenchymal Stem Cells in Differentiation of Naive T-Cells into Anti-Inflammatory Regulatory T-Cell or Proinflammatory Helper T-Cell 17 Population

  2012cited by this paper
• The immunomodulatory capacity of mesenchymal stem cells.

  2012cited by this paper
• Immunomodulatory Effects of Bone Marrow-Derived Mesenchymal Stem Cells in a Swine Hemi-Facial Allotransplantation Model

  2012cited by this paper
• Hepatic macrophage migration and differentiation critical for liver fibrosis is mediated by the chemokine receptor C‐C motif chemokine receptor 8 in mice

  2012cited by this paper
• Human Mesenchymal Stem/Stromal Cells Cultured as Spheroids are Self‐activated to Produce Prostaglandin E2 that Directs Stimulated Macrophages into an Anti‐inflammatory Phenotype

  2012cited by this paper
• Effect of allogeneic bone marrow–derived mesenchymal stem cells transplantation in a polyI:C-induced primary biliary cirrhosis mouse model

  2011cited by this paper
• Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury

  2011cited by this paper
• Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome.

  2011cited by this paper
• Immunogenicity and Immunomodulatory Properties of Umbilical Cord Lining Mesenchymal Stem Cells

  2011cited by this paper
• In vivo consequences of liver‐specific interleukin‐22 expression in mice: Implications for human liver disease progression

  2011cited by this paper
• Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short‐term and long‐term outcomes

  2011cited by this paper
• Multipotent Adult Progenitor Cells Prevent Macrophage-Mediated Axonal Dieback and Promote Regrowth after Spinal Cord Injury

  2011cited by this paper
• A Whole-Organ Regenerative Medicine Approach for Liver Replacement

  2011cited by this paper
• Bone marrow mononuclear cell therapy for patients with cirrhosis: a Phase 1 study

  2011cited by this paper
• Implications of the immunoregulatory functions of mesenchymal stem cells in the treatment of human liver diseases

  2011cited by this paper
• Mesenchymal stromal cells mediate a switch to alternatively activated monocytes/macrophages after acute myocardial infarction

  2011influential reference
• Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function

  2011cited by this paper
• Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis.

  2011cited by this paper
• Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells

  2011cited by this paper
• Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

  2010cited by this paper
• Role of IL-17 and Th17 Cells in Liver Diseases

  2010cited by this paper
• Anti‐fibrotic effect of chorionic plate‐derived mesenchymal stem cells isolated from human placenta in a rat model of CCl4‐injured liver: Potential application to the treatment of hepatic diseases

  2010cited by this paper
• Type 1 T Helper Cells Induce the Accumulation of Myeloid‐Derived Suppressor Cells in the Inflamed Tgfb1 Knockout Mouse Liver

  2010cited by this paper
• Intravenous Administration of Bone Marrow Mesenchymal Stem Cells Benefits Experimental Autoimmune Myasthenia Gravis Mice Through an Immunomodulatory Action

  2010cited by this paper
• The significance of CD14+ monocytes in peripheral blood stem cells for the treatment of rat liver cirrhosis.

  2010cited by this paper
• Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.

  2010cited by this paper
• Pathology of Immune-Mediated Liver Injury

  2010cited by this paper
• Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis.

  2010cited by this paper
• Stem Cell Therapy Improves the Outcome of Liver Resection in Cirrhotics

  2010cited by this paper
• Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease.

  2010cited by this paper
• Autologous Hematopoietic Stem Cell Transplantation in 48 Patients with End-Stage Chronic Liver Diseases

  2010cited by this paper
• Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study

  2010cited by this paper
• Nerve growth factor-mediated paracrine regulation of hepatic stellate cells by multipotent mesenchymal stromal cells.

  2009cited by this paper
• Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I–II clinical trial

  2009cited by this paper
• Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside?

  2008cited by this paper
• Peripheral blood monocytes from the decompensated liver cirrhosis could migrate into nude mouse liver with human hepatocyte-markers expression.

  2008cited by this paper
• Controlled trials in hepatitis B virus-related decompensate liver cirrhosis: peripheral blood monocyte transplant versus granulocyte-colony-stimulating factor mobilization therapy.

  2008cited by this paper
• Autologous Infusion of Expanded Mobilized Adult Bone Marrow-Derived CD34+ Cells Into Patients With Alcoholic Liver Cirrhosis

  2008cited by this paper
• Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.

  2008cited by this paper
• Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease.

  2007cited by this paper
• Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis.

  2007cited by this paper
• Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.

  2007cited by this paper
• Immunomodulation of activated hepatic stellate cells by mesenchymal stem cells.

  2007cited by this paper
• Scar-Associated Macrophages Are a Major Source of Hepatic Matrix Metalloproteinase-13 and Facilitate the Resolution of Murine Hepatic Fibrosis1

  2007cited by this paper
• Peripheral blood monocytes from patients with HBV related decompensated liver cirrhosis can differentiate into functional hepatocytes

  2007cited by this paper
• Autologous bone marrow cells in the treatment of cirrhosis of the liver

  2007cited by this paper
• Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience.

  2007cited by this paper
• Characterization of the Potential Subpopulation of Bone Marrow Cells Involved in the Repair of Injured Liver Tissue

  2007cited by this paper
• Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing

  2007cited by this paper
• Improved Liver Function in Patients with Liver Cirrhosis After Autologous Bone Marrow Cell Infusion Therapy

  2006cited by this paper
• Mesenchymal Stem Cells Inhibit Generation and Function of Both CD34+-Derived and Monocyte-Derived Dendritic Cells1

  2006cited by this paper
• Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells.

  2006cited by this paper
• Characterization and Clinical Application of Human CD34+ Stem/Progenitor Cell Populations Mobilized into the Blood by Granulocyte Colony‐Stimulating Factor

  2006cited by this paper
• The liver as an immunological organ

  2006cited by this paper
• Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats.

  2005cited by this paper
• Human mesenchymal stem cells modulate allogeneic immune cell responses.

  2005cited by this paper
• Human Adult CD34− Progenitor Cells Functionally Express the Chemokine Receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but Not CXCR4

  2005influential reference
• Markers of cell activation and apoptosis in bone marrow mononuclear cells of patients with autoimmune hepatitis type 1 and primary biliary cirrhosis.

  2005cited by this paper
• Portal Application of Autologous CD133+ Bone Marrow Cells to the Liver: A Novel Concept to Support Hepatic Regeneration

  2005cited by this paper
• The liver as an immunological organ

  2004cited by this paper
• Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

  2004cited by this paper
• In vitro hepatic differentiation of human mesenchymal stem cells

  2004cited by this paper
• Transplantation of bone marrow cells reduces CCl4‐induced liver fibrosis in mice

  2004cited by this paper
• Effects of Mesenchymal Stem Cells on Differentiation, Maturation, and Function of Human Monocyte-Derived Dendritic Cells

  2004cited by this paper

• A Clinic Study on Long-term Efficacy and Safety of Autologous Peripheral Blood Stem Cell Transplantation in Patients with Decompensated Hepatitis B Cirrhosis.

  2023cites this paper
• Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver Cirrhosis

  2023cites this paper
• Efficacy and safety of mesenchymal stem cell therapy in liver cirrhosis: a systematic review and meta-analysis

  2023cites this paper
• (Volume 3) Immune Privilege Signatures of Embryonic and Adult Stem Cells

  2021cites this paper
• Mesenchymal Stromal Cell Secretome for Tissue Repair

  2019cites this paper
• Long‐term Outcomes of Autologous Peripheral Blood Stem Cell Transplantation in Patients With Cirrhosis

  2019cites this paper
• Liver regeneration: Influence-factors and mechanism of mesenchymal stem cell transplantation

  2019cites this paper
• Hepatitis B viral infection of hepatic progenitor cells. Resolving unresolved questions?

  2016cites this paper
• Mesenchymal Stem/Stromal Cells in Liver Fibrosis: Recent Findings, Old/New Caveats and Future Perspectives

  2015cites this paper
• Effect of bone marrow mesenchymal stem cells transplantation on the serum and liver HMGB1 expression in rats with acute liver failure.

  2015cites this paper